Inventor · disambiguated record
Sathesh Bhat
Also filed as: BHAT SATHESH · BHAT SATHESH P · BHAT SATHESH PANGALA
10 granted patents·9 pending applications·151 citations·filing 2009–2023
89Inventor score
Files withRELAY THERAPEUTICS INC4SCHROEDINGER INC4GILEAD APOLLO LLC3JANSSEN PHARMACEUTICA NV2MERCK SHARP & DOHME2
Top patents by PatentIndex Score
19 records- 0195US10472374B2ACC inhibitors and uses thereofGILEAD APOLLO LLC·Filed 2018·Granted Nov 12, 2019·10 cites·20 claims
- 0295US9944655B2ACC inhibitors and uses thereofGILEAD APOLLO LLC·Filed 2016·Granted Apr 17, 2018·16 cites·9 claims
- 0394US9453026B2ACC inhibitors and uses thereofGILEAD APOLLO INC·Filed 2015·Granted Sep 27, 2016·37 cites·4 claims
- 0494US8969557B2ACC inhibitors and uses thereofNIMBUS APOLLO INC·Filed 2012·Granted Mar 3, 2015·70 cites·10 claims
- 0586US11701354B2Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitorsRELAY THERAPEUTICS INC·Filed 2018·Granted Jul 18, 2023·3 cites·40 claims
- 0685US11591336B2Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitorsRELAY THERAPEUTICS INC·Filed 2018·Granted Feb 28, 2023·3 cites·54 claims
- 0784US8987195B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 24, 2015·9 cites·27 claims
- 0881US11629145B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2017·Granted Apr 18, 2023·3 cites·18 claims
- 0981US2023317214A1Methods for predicting an active set of compounds having alternative cores, and drug discovery methods involving the sameSCHROEDINGER INC·Filed 2023·Application pending·0 cites
- 1070US2020102323A1Acc inhibitors and uses thereofGILEAD APOLLO LLC·Filed 2019·Application pending·0 cites
- 1156US2014243290A1Aminopyrimidines as SYK InhibitorsALTMAN MICHAEL D·Filed 2014·Application pending·0 cites
- 1255US11710543B2Methods for predicting an active set of compounds having alternative cores, and drug discovery methods involving the sameSCHROEDINGER INC·Filed 2018·Granted Jul 25, 2023·0 cites·9 claims
- 1351US2024199634A1Cyclic compounds and methods of using sameSCHROEDINGER INC·Filed 2022·Application pending·0 cites
- 1450US2023365584A1Heterocyclic pericondensed cdc7 kinase inhibitors for the treatment of cancerSCHROEDINGER INC·Filed 2021·Application pending·0 cites
- 1549US2020392161A1Shp2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1647US2011021532A1Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturaseMERCK FROSST CANADA LTD·Filed 2009·Application pending·0 cites
- 1742US2021284659A1Inhibitors of beta secretaseJANSSEN PHARMACEUTICA NV·Filed 2018·Application pending·0 cites
- 1841US2020010482A1Inhibitors of beta secretaseJANSSEN PHARMACEUTICA NV·Filed 2018·Application pending·0 cites
- 1940US10875851B2Factor XIIa inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Dec 29, 2020·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →